A PIL has been moved in the Delhi High Court seeking directions to the Centre and the Medical Council of India (MCI) to ensure that doctors prescribe medicines by writing their generic names legibly and preferably in capital letters.
The petition seeks strict compliance of regulation 1.5 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which mandates every physician "prescribe drugs with generic names legibly and preferably in capital letters".
The plea by Amit Sahni, a lawyer by profession, contends that MCI in 2017 had directed all medical practitioners registered under the Indian Medical Council Act to use generic names, but unfortunately no one takes it seriously.
The petition claims that "despite issuance of various notifications and circulars issued by respondent 2 (MCI) to practicing doctors in this regard and even after launching of Pradhan Mantri Bhartiya Janaushdhi Pariyojana (PMBJP) by respondent 1 (Centre), the respondents have failed to yield any result."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app